Mitochondrial function changes as we age

September 4, 2015 by Heather Zeiger, Medical Xpress report
Mitochondria. Credit: Wikipedia commons

(—A new study finds that age-related onset of type 2 diabetes and impaired glucose tolerance may be due to the lowered ability of muscle mitochondria to switch from metabolizing fatty acids to metabolizing glucose in healthy elderly people compared to young people. The study was reported in the Proceedings of the National Academy of Sciences.

Americans over the age of 65 are more likely to develop or intolerance. The reasons for this are largely unknown, but studies have shown that muscle resistance, increased intramyocellular lipid content (IMCL, triglycerides located within muscles), and decreased metabolic rates are related to aging. Because of this, scientists are interested in studying differences in the function of mitochondria located within muscle cells of elderly people compared young people.

However, singling out mitochondrial function in muscle cells has been difficult to do using typical indirect calorimetry methods. Typically, indirect calorimetry methods provide information about the whole body's basal metabolic rate, not just metabolism within muscle cells. Additionally, it is reliant on blood flow, which can change due to changes in several factors.

In an effort to gain a more accurate picture of mitochondrial function in muscle cells, Kitt Falk Petersen, Katsutaro Morino, Tiago C. Alves, Richard G. Kibbey, Sylvie Dufour, Saki Sono, Peter S. Yoo, Gary W. Cline, and Gerald I. Shulman from Yale University School of Medicine developed a method for studying the flux of two key metabolic enzymes using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and 13C-labeled glucose.

During cell metabolism, pyruvate enters the mitochondria, undergoes a series of reactions that produce carbon dioxide, water and acetyl-CoA. In the first step of the process, the pyruvate reaction is catalyzed by an enzyme called pyruvate dehydrogenase. Acetyl-CoA converts to citrate through the enzyme citrate synthase. This study assessed the ratio of the flux of pyruvate dehydrogenase to citrate synthase within muscle mitochondria after a twenty-four hour fast and after insulin stimulation in healthy, non-smoking elderly subjects (average age was 69 years). They were matched with young subjects (average age was 27 years).

First, Petersen et al. did an oral glucose test and checked the subject's IMCL content. After fasting, elderly subjects had higher plasma glucose concentrations than the younger subjects, but other factors, such as insulin concentration, were the same for both. After ingestion of glucose, the concentration of glucose and insulin in plasma were found to be significantly higher in the elderly subjects. Proton magnetic resonance spectroscopy showed that IMCL content was 73% higher in elderly subjects.

After assessing the subject's and IMCL content, Petersen, et al. then examined the subject's response to increased plasma insulin levels utilizing hyperglycemic-euglycemic clamp studies combined with stable isotopes of glucose. Both the young and elderly groups' insulin levels were increased while their glucose levels were kept the same by a variable infusion of glucose. Under these conditions of matched plasma glucose and increased plasma insulin concentrations elderly subjects metabolized glucose at a rate that was 25% slower than the younger subjects. This reduced rate of insulin-stimulated glucose metabolism could be attributed to reduced rates of nonoxidative glucose disposal due to reduced activity of ATK2, an important insulin signaling protein.

Finally, the flux of pyruvate dehydrogenase and citrate synthase in muscle cells was assessed by taking muscle biopsies before and after insulin stimulation and using their LC/MS/MS technique. After fasting, fluxes for both enzymes were the same for the and the young subjects. This was different from the indirect calorimetry method that showed a higher respiratory quotient in the elderly group than the younger group, indicating that the elderly group had a lower metabolic rate. Their muscle-specific technique, however, was able to single-out muscle cells. Their studies showed that after fasting, both groups had a similar rate of pyruvate dehydrogenase-to-citrate synthase flux in . After insulin stimulation, the ratio of the flux of pyruvate dehydrogenase-to-citrate synthase increased three-fold in the younger , while the rate did not change in the elderly.

These results indicate that after insulin stimulation, the younger group switched from lipid oxidation to glucose oxidation, while this switch did not occur in the elderly group. This points to a problem in insulin signaling in the muscle associated with aging and may be a contributing factor to the higher incidence of type 2 diabetes and in people.

Explore further: New strategy to lower blood sugar may help in diabetes treatment

More information: "Effect of aging on muscle mitochondrial substrate utilization in humans" PNAS, DOI: 10.1073/pnas.1514844112

Previous studies have implicated age-associated reductions in mitochondrial oxidative phosphorylation activity in skeletal muscle as a predisposing factor for intramyocellular lipid (IMCL) accumulation and muscle insulin resistance (IR) in the elderly. To further investigate potential alterations in muscle mitochondrial function associated with aging, we assessed basal and insulin-stimulated rates of muscle pyruvate dehydrogenase (VPDH) flux relative to citrate synthase flux (VCS) in healthy lean, elderly subjects and healthy young body mass index- and activity-matched subjects. VPDH/VCS flux was assessed from the 13C incorporation from of infused [1-13C] glucose into glutamate [4-13C] relative to alanine [3-13C] assessed by LC-tandem MS in muscle biopsies. Insulin-stimulated rates of muscle glucose uptake were reduced by 25% (P < 0.01) in the elderly subjects and were associated with ∼70% (P < 0.04) increase in IMCL, assessed by 1H magnetic resonance spectroscopy. Basal VPDH/VCS fluxes were similar between the groups (young: 0.20 ± 0.03; elderly: 0.14 ± 0.03) and increased approximately threefold in the young subjects following insulin stimulation. However, this increase was severely blunted in the elderly subjects (young: 0.55 ± 0.04; elderly: 0.18 ± 0.02, P = 0.0002) and was associated with an ∼40% (P = 0.004) reduction in insulin activation of Akt. These results provide new insights into acquired mitochondrial abnormalities associated with aging and demonstrate that age-associated reductions in muscle mitochondrial function and increased IMCL are associated with a marked inability of mitochondria to switch from lipid to glucose oxidation during insulin stimulation.

Related Stories

New strategy to lower blood sugar may help in diabetes treatment

September 3, 2015
Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar. But new research at Washington University School of Medicine in St. Louis suggests a different strategy: slowing ...

Pyruvate oxidation is critical determinant of pancreatic islet number and beta-cell mass

August 5, 2014
Researchers at the University at Buffalo, led by Dr. Mulchand Patel and also at Lawson Health Research Institute and Western Ontario, London, Canada, led by Dr. David Hill, collaboratively evaluated the role of the mitochondrial ...

Targeting glucose production in liver may lead to new diabetes therapies

September 3, 2015
High blood sugar is a defining characteristic of Type 2 diabetes and the cause of many of the condition's complications, including kidney failure, heart disease, and blindness. Most diabetes medications aim to maintain normal ...

Effects of n-3 PUFAs on insulin sensitivity unclear

April 14, 2015
(HealthDay)—Dietary n-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), do not appear to have clinically meaningful effects on peripheral or hepatic insulin sensitivity ...

Research team identifies link between inflammation and type 2 diabetes

February 5, 2015
A Yale-led research team has identified the molecular mechanism by which insulin normally inhibits production of glucose by the liver and why this process stops working in patients with type 2 diabetes, leading to hyperglycemia.

Insulin pump reduces mortality from cardiovascular disease by almost 50%

August 11, 2015
People with type 1 diabetes who use insulin pump therapy face almost 50% less risk of dying from cardiovascular disease than those who take insulin by multiple daily injections. The British Medical Journal has published a ...

Recommended for you

Breakthrough article on mechanistic features of microRNA targeting and activity

March 23, 2018
Giovanna Brancati and Helge Grosshans from the FMI have described target specialization of miRNAs of the let-7 family. They identified target site features that determine specificity, and revealed that specificity can be ...

Boosting enzyme may help improve blood flow, fitness in elderly

March 22, 2018
As people age, their blood-vessel density and blood flow decrease, which is why it's harder to maintain muscle mass after 40 and endurance in the later decades, even with exercise. This vascular decline is also one of the ...

Scientists pinpoint cause of vascular aging in mice

March 22, 2018
We are as old as our arteries, the adage goes, so could reversing the aging of blood vessels hold the key to restoring youthful vitality?

Sulfur amino acid restriction diet triggers new blood vessel formation in mice

March 22, 2018
Putting mice on a diet containing low amounts of the essential amino acid methionine triggered the formation of new blood vessels in skeletal muscle, according to a new study from Harvard T.H. Chan School of Public Health. ...

Cold can activate body's 'good' fat at a cellular level, study finds

March 21, 2018
Lower temperatures can activate the body's 'good' fat formation at a cellular level, a new study led by academics at The University of Nottingham has found.

Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning

March 21, 2018
A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Sep 04, 2015

Just so we have some more facts to compare this article to...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.